Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease. Issue 1 (20th November 2020)

• Record Type: Journal Article
• Authors: Yee, Marianne E. M.; Batsuli, Glaivy; Chonat, Satheesh; Park, Sunita
• Is Part Of: Clinical case reports. Volume 9:Issue 1(2021)
• Page Start: 457
• Page End: 460
• Publication Date: 2020-11-20
• Subjects: acquired Von Willebrand disease -- priapism -- sickle cell disease -- thrombocytosis; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.3556
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy. Abstract : Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.